Complications in Patients with Severe Left Ventricular Dysfunction and Temporary Transvenous Pacemaker

Device-Specific Complications

The American College of Cardiology notes that device-related complications occur in 14-40% of cases in patients with temporary transvenous pacemakers, with severe left ventricular dysfunction (ejection fraction 20%) facing substantially elevated risks across multiple domains 1, 2
Lead dislodgement occurs in 16% of patients with temporary transvenous pacing, with 50% happening within the first 24 hours, according to the American Heart Association 3, 4
The American Heart Association recommends that the stiff, non-fixated temporary leads lack the active and passive fixation mechanisms of permanent systems, making perforation through the right ventricular free wall or interventricular septum more likely 5
Loss of capture can result from lead dislodgement, lead fractures, loose connections between lead wires and external generator, battery depletion, or sudden increases in pacing threshold, as stated by the European Heart Society 3, 6

The European Heart Society notes that right ventricular pacing alone (typical with temporary transvenous systems) causes ventricular dyssynchrony, which further impairs cardiac output in patients with pre-existing severe LV dysfunction 2
Any malfunction leading to bradycardia or asystole can rapidly cause hypotension, acute heart failure exacerbation, cardiogenic shock, or cardiac arrest, according to the American College of Cardiology 4

The American College of Cardiology states that the risk of infectious complications in permanent pacemaker placement is significantly increased in patients who have a temporary pacing wire before permanent implant 1
Prolonged temporary pacing increases infection risk, with longer use of temporary transvenous pacing restricting the patient to being bedridden, with accompanying risks for infection and thromboembolic events, as noted by the European Heart Journal 6

Patients with severe LV dysfunction (EF 20%) have substrate for ventricular tachycardia and fibrillation, according to the American Heart Association 4
The large pacing artifact may obscure or mimic the QRS complex, making it difficult to determine ventricular capture or detect underlying arrhythmias, as stated by the American Heart Association 3

The American Heart Association recommends that all patients with temporary transvenous pacing wires require continuous arrhythmia monitoring until either pacing is no longer necessary and the device is removed or it is replaced with a permanent device 3, 7
Confirm mechanical capture by assessing arterial pulse or waveform, not just electrical capture on ECG, as the large pacing artifact can be misleading, according to the American College of Cardiology 8

The American College of Cardiology advises against relying solely on ECG evidence of electrical capture without confirming actual mechanical cardiac contraction and perfusion 8
Never assume stable pacing function—dislodgement can occur at any time, not just in the first 24 hours, as noted by the American Heart Association 3

Consider externalized permanent active fixation lead if prolonged temporary pacing is required (>24-48 hours), as these have lower dislodgement rates and allow for safer extended use, according to the American College of Cardiology 4
Cardiology consultation for permanent pacemaker evaluation should occur urgently, as temporary pacing should be as brief as possible given the high complication rates (14-40%), as stated by the American College of Cardiology 1, 2, 4

The American Heart Association recommends verifying mechanical capture independently of ECG, as large pacing artifacts can obscure the QRS complex and create false impressions of capture 9
The American College of Cardiology suggests using arterial pressure monitoring or pulse oximetry to confirm actual cardiac contraction and perfusion 9

For hemodynamically unstable patients, the American Heart Association recommends initiating transcutaneous pacing immediately as a bridge while preparing for definitive transvenous lead repositioning 10
The American College of Cardiology advises preparing for emergent transvenous lead repositioning under fluoroscopy or ultrasound guidance, with maintenance of vascular access appropriate for emergent pacing 11, 12

The American Heart Association states that standard temporary transvenous pacing wires have a dislodgement rate of 16%, with 50% occurring within the first 24 hours 9, 10
The American College of Cardiology recommends replacing standard temporary transvenous pacing wires with permanent pacemakers or removing them as soon as clinically feasible, ideally within 2-19 days depending on clinical stability 9, 10
The Heart Rhythm Society notes that lead dislodgement occurs in 1-2% of pacemaker/ICD cases and up to 5.7% after cardiac resynchronization device insertion 9

The American College of Cardiology recommends maintaining transvenous pacing ability with continuous cardiac monitoring for at least 24 hours in patients with pre-existing right bundle branch block (RBBB) 11, 12
The American Heart Association suggests maintaining temporary pacemaker for at least 24 hours to assess for conduction recovery in patients with transient high-grade AV block 12